Tata Capital Healthcare Fund aims to exit over half of its portfolio companies from its new ₹2,500 crore fund via IPOs, pivoting away from traditional strategic sales. The firm is raising ticket sizes while targeting growth drivers like medical devices, and single-specialty chains.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.